drugset / Trial / NCT02066129

Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

NCT02066129

Phase 3 Completed 254 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to determine whether, in children receiving low-dose inhaled corticosteroids (ICS), quintupling the dose of inhaled corticosteroids at the onset of symptoms previously associated with upper respiratory illnesses and subsequent asthma exacerbations reduces the rate of severe asthma exacerbations treated with oral corticosteroids.

Timeline

Start
2014-07
Primary completion
2017-04-21
Completion
2017-04-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 44 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 220 ug Inhaled

Indications